CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced ...

One of the unique characteristics of blood cancer is that it is not able to be seen. There are no surgery scars, loss of hair ...

The FDA granted orphan drug designation to MVdeltaC, a measles virus-based immunotherapy, for pleural mesothelioma, ...

Patients with oligometastatic lung cancer may live longer with surgery, but experts stress the need for multidisciplinary ...

Katherine has an exquisite instinct for understanding that there is a context to each patient’s diagnosis that is just as ...

Akeega Combo Delays Progression in HRR+ Castration-Sensitive Prostate Cancer ...

Natalie Schnaitmann discusses urgent supportive care gaps younger women with cancer encounter, and how they affect long-term quality of life.

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

I reflect on finding peace, purpose and presence after my diagnosis through a creative writing exercise rooted in mindfulness ...

Iopofosine-131 received FDA breakthrough status for relapsed or refractory Waldenstrom macroglobulinemia, showing strong ...

Survival outcomes favored the higher dose: more than 93% of patients in the 70 Gy group were alive one year after treatment, ...

Columvi plus chemo had enhanced survival outcomes vs Rituxan plus chemo in patients with relapsed/refractory diffuse large B-cell lymphoma. Among patients with relapsed/refractory diffuse large B-cell ...